executive management committee

Dr Ash is the Managing Director of the company, taking up the position in February 2007, having previously been the group’s Chief Financial Officer. A Chartered Accountant with a PhD in Mycology from Sheffield University, Nick has reshaped the group by refocusing activities in the UK, playing a key role in the disposal of the group’s Dubai operations in 2006. Nick has also overseen the acquisition of Geneservice Limited (July 2007) and Autogen Bioclear UK Limited (March 2008) thereby acquiring the technologies and expertise necessary for the group's current and planned range of services. He worked at Eastern Airways and spent nine years with KPMG before joining Source BioScience in 2005.

Dr Leaves is the Operations Director of the Company having held a similar position at Geneservice Ltd prior to their acquisition by Medical Solutions™ in July 2007. Before Geneservice, Nick worked for 4 years as DNA sequencing production manager on high-throughput projects for the Medical Research Council, and worked for 5 years on Asthma and Eczema gene hunting projects at Oxford University. Originally, Nick qualified as a microbiologist and worked in the NHS. It was here that he completed a PhD in 1995 on the molecular methods used to characterise meningitis outbreaks whilst also considering the impact of the HIB meningitis vaccine that has now been introduced UK-wide.

Ms Barrett joined the Company in 2001 as a cofounder of Pathlore Limited now Medical Solutions™ (Nottingham) Limited, a wholly owned subsidiary of Source BioScience plc. Eileen graduated from Sheffield University with a BSc Hons in Genetics and spent a year as a trainee accountant before undertaking a PGCE and qualifying as a teacher. She taught Physics for 13 years eventually becoming acting Head of Physics at the German Swiss International School in Hong Kong. Whilst teaching, Eileen undertook a conversion to Law at Hong Kong University and returned to the UK in 1994 to complete the LPC at Nottingham Law School. Following law school Eileen worked for the Brussels based Federation of European Cancer Societies leading the construction of a pan European Medical Education Project, which won European Commission funding in 1999.

Mr Coombes joined Medical Solutions™ in November 2002 as Commercial Director and was appointed Director, Cytology in July 2004. With the acquisition of Geneservice in July 2007 he was appointed Head of Healthcare. Roger previously worked in the pharmaceutical industry for a number of companies including Pfizer, Rhone Poulenc and, for 25 years, the pharmaceutical Division of Boots where he held various senior UK marketing positions before being seconded to their M&A Group. He was for a time Managing Director of Boots GmbH based in Germany, Director of Business Development in Nottingham and finally Boots Export Director based in Nottingham. He joined BASF, when Boots Pharmaceuticals was sold to that company, and was appointed Director, International Pain Management Group. Roger has a BSc in Biochemistry (London) and a Diploma in Marketing.

Professor Ellis is Medical Director of Medical Solutions™ and was a cofounder of Pathlore Limited now Medical Solutions (Nottingham) Limited, a wholly owned subsidiary of Source BioScience plc. He is an experienced diagnostic histopathologist with an international reputation in diagnosis and translational research in breast disease, particularly classification of breast cancer and evaluation of prognostic factors. He has authored over 300 scientific publications, chapters in medical textbooks and specialist textbooks in pathology and is an experienced lecturer. He is a Specialty Advisor of The Royal College of Pathologists, Chairman of the UK National Co-coordinating Committee for Breast Pathology, Steering Committee Member of The European Group for Breast Screening Pathology and President of the International Society of Breast Pathology. He has acted as an advisor to the Department of Health, International Union against Cancer, World Health Organisation and International Agency for Research on Cancer.

Dr Murray joined Medical Solutions™ in January 2005. Prior to that, he was Reader in Oncology at Nottingham University and Director of the CRUK Tumour Cytokine Biology Group since 1994. The interests of his group included tumour angiogenesis and novel mechanisms employed by tumours to evade the host immune response. Cliff has a BSc in Biochemistry from St. Andrews, and a PhD in Pathology and Biochemistry from Cambridge.

Mr Palmer joined Medical Solutions™ in October 2002 during which time he has undertaken the roles of Project Manager, Projects & Data Manager, Head of Operations and most recently Head of Client Relations and Contract Management. Prior to joining Medical Solutions, Simon worked for over 15 years within the health informatics field, principally within primary and secondary care, including 8 years as the Development Manager for a Nottingham-based software house developing integrated clinical information systems for women's and children's health. Simon has an MSc in Health Information Management from the University of Wales (Aberystwyth).